Cargando…

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands

BACKGROUND: Pertussis is a respiratory disease and still endemic despite high vaccination coverage. In the Dutch national immunisation programme (NIP) whole cell pertussis (wP) priming vaccines for infants were replaced by acellular pertussis (aP) priming vaccines in 2005. Serosurveillance gives the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versteegen, Pauline, Berbers, Guy A.M., Smits, Gaby, Sanders, Elisabeth A.M., van der Klis, Fiona R.M., de Melker, Hester E., van der Maas, Nicoline A.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589709/ https://www.ncbi.nlm.nih.gov/pubmed/34806066 http://dx.doi.org/10.1016/j.lanepe.2021.100196

Ejemplares similares

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles
por: van der Lee, Saskia, et al.
Publicado: (2018)

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011
por: McDonald, Scott A., et al.
Publicado: (2015)

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection
por: van der Lee, Saskia, et al.
Publicado: (2017)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness
por: van der Maas, Nicoline A. T., et al.
Publicado: (2019)

Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of Bordetella pertussis Despite High Vaccination Rates
por: Scott, Susana, et al.
Publicado: (2015)

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
por: Versteegen, Pauline, et al.
Publicado: (2022)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
por: Knuutila, Aapo, et al.
Publicado: (2022)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks
por: Smits, Gaby, et al.
Publicado: (2013)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy – a prospective, observational cohort study from the United Kingdom
por: Rice, T. F., et al.
Publicado: (2019)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants
por: Immink, Maarten M., et al.
Publicado: (2021)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.
por: de Melker, H E, et al.
Publicado: (2000)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Maternal vaccination against pertussis as part of the national immunization program: a qualitative evaluation among obstetric care providers one year after the implementation in December 2019
por: Immink, Maarten M., et al.
Publicado: (2023)

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
por: de Melker, H E, et al.
Publicado: (1997)

Bordetella pertussis Induces Interferon Gamma Production by Natural Killer Cells, Resulting in Chemoattraction by Respiratory Epithelial Cells
por: den Hartog, Gerco, et al.
Publicado: (2020)

Mass Spectrometry-Based Quantification of the Antigens in Aluminum Hydroxide-Adjuvanted Diphtheria-Tetanus-Acellular-Pertussis Combination Vaccines
por: van der Maas, Larissa, et al.
Publicado: (2022)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
Publicado: (2021)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial
por: Gillard, Joshua, et al.
Publicado: (2022)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s09pu7f029i9emehbhpoclf3p4